Myoung-Seo Koo

Title: Myoung-Seo Koo: Innovator in Therapeutic Methods

Introduction

Myoung-Seo Koo is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of therapeutic methods, particularly through her innovative research and development of boronated metalloporphyrine compounds. With a total of 3 patents, her work has the potential to impact various medical applications.

Latest Patents

One of her latest patents focuses on boronated metalloporphyrine and therapeutic methods. This invention involves carborane substituted porphyrin compounds complexed with a metal or transition metal, which have been found to selectively inhibit viral aspartyl proteases. These transition metal complexes are not only useful therapeutically in boron neutron capture therapy (BNCT) but also serve as agents for MR contrast enhancement. The preferred compounds utilize the dipotassium salt of 2,4-bis-[.alpha.,.beta.-(1,2-dicarbaclosododecaborane carboxy)ethyl]deuteroporphyrin, complexed with a metal or transition metal. These compounds are well solubilized in water and are suitable for oral administration.

Career Highlights

Myoung-Seo Koo is affiliated with the University of California, where she continues her research and development efforts. Her work has garnered attention for its innovative approach to therapeutic applications, particularly in the realm of drug delivery systems.

Collaborations

Myoung-Seo Koo collaborates with Stephen B Kahl, contributing to the advancement of their shared research interests.

Conclusion

Myoung-Seo Koo's contributions to the field of therapeutic methods through her innovative patents highlight her role as a leading inventor. Her work promises to enhance medical treatments and improve patient outcomes.